TCT-690 Safety and Clinical Efficacy of Sideguard® Stent for Treatment of Bifurcation Lesions: Interim Results from the European Sideguard® Bifurcation Registry Study
Data collected include Patient demographics, PCI procedure and clinical follow-up up to 1 yr. Clinical end point studied includes death, myocardial infarction (MI) and target lesion revascularisation (TLR).
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2012-10, Vol.60 (17), p.B201-B201 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Data collected include Patient demographics, PCI procedure and clinical follow-up up to 1 yr. Clinical end point studied includes death, myocardial infarction (MI) and target lesion revascularisation (TLR). |
---|---|
ISSN: | 0735-1097 1558-3597 |
DOI: | 10.1016/j.jacc.2012.08.728 |